Designing a Library of TCR T Cell Therapy Products that Precisely Target Mutant KRAS
- Selecting and validating high value KRAS targets systemized cell biology assays
- Defining potent and selective TCR assets that form the foundation of differentiated TCR T therapy products
- Scaling manufacturing and clinical trial design to enable meet the needs of highly personalized cell therapies